Research ArticleOriginal Article
Open Access

Clinical and ultrasonographic features in cancer risk stratification of indeterminate thyroid nodules

Saad M. Alqahtani, Sultan F. Alanesi, Waqas S. Mahmood, Yassin M. Moustafa, Laila M. Moharram, Nawaf F. Alharthi, Attiya M. Alzahrani and Yousef S. Alalawi
Saudi Medical Journal May 2022, 43 (5) 473-478; DOI: https://doi.org/10.15537/smj.2022.43.5.20220045

References

  1. 1.↵
    1. Zhang J,
    2. Liu BJ,
    3. Xu HX,
    4. Xu JM,
    5. Zhang YF,
    6. Liu C, et al.
    Prospective validation of an ultrasound-based Thyroid Imaging Reporting and Data System (TI-RADS) on 3980 thyroid nodules. Int J Clin Exp Med 2015; 8: 5911–5917.
    OpenUrl
  2. 2.↵
    1. Wu H,
    2. Zhang B,
    3. Cai G,
    4. Li J,
    5. Gu X.
    American College of Radiology Thyroid Imaging Report and Data System combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules. PLoS One 2019; 14: e0219383.
    OpenUrl
  3. 3.↵
    1. Modi L,
    2. Sun W,
    3. Shafizadeh N,
    4. Negron R,
    5. Yee-Chang M,
    6. Zhou F, et al.
    Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules. Cancer Cytopathol 2020; 128: 470–481.
    OpenUrl
  4. 4.↵
    1. Horvath E,
    2. Majlis S,
    3. Rossi R,
    4. Franco C,
    5. Niedmann JP,
    6. Castro A, et al.
    An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 2009; 94: 1748–1751.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Park JY,
    2. Lee HJ,
    3. Jang HW,
    4. Kim HK,
    5. Yi JH,
    6. Lee W, et al.
    A proposal for a thyroid imaging reporting and data system for ultrasound features of thyroid carcinoma. Thyroid 2009; 19: 1257–1264.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Kwak JY,
    2. Han KH,
    3. Yoon JH,
    4. Moon HJ,
    5. Son EJ,
    6. Park SH, et al.
    Thyroid Imaging Reporting and Data System for US features of nodules: a step in establishing better stratification of cancer risk. Radiology 2011; 260: 892–899.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.
    1. Russ G,
    2. Bigorgne C,
    3. Royer B,
    4. Rouxel A,
    5. Bienvenu-Perrard M.
    [The Thyroid Imaging Reporting and Data System (TIRADS) for ultrasound of the thyroid]. J Radiol 2011; 92: 701–713. (in French).
    OpenUrlPubMedWeb of Science
  8. 8.↵
    1. Russ G,
    2. Royer B,
    3. Bigorgne C,
    4. Rouxel A,
    5. Bienvenu-Perrard M,
    6. Leenhardt L.
    Prospective evaluation of Thyroid Imaging Reporting and Data System on 4550 nodules with and without elastography. Eur J Endocrinol 2013; 168: 649–655.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Tessler FN,
    2. Middleton WD,
    3. Grant EG,
    4. Hoang JK,
    5. Berland LL,
    6. Teefey SA, et al.
    ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017; 14: 587–595.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Cibas ES,
    2. Ali SZ.
    The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2009; 19: 1159–1165.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Alqahtani S,
    2. Alsobhi S,
    3. Alsalloum RI,
    4. Najjar SN,
    5. Al-Hindi HN.
    Surgical outcome of thyroid nodules with atypia of undetermined significance and follicular lesion of undetermined significance in fine needle aspiration biopsy. World J Endoc Surg 2017; 9: 100–103.
    OpenUrl
  12. 12.↵
    1. Al Dawish M,
    2. Alwin Robert A,
    3. Al Shehri K,
    4. Hawsawi S,
    5. Mujammami M,
    6. Al Basha IA, et al.
    Risk stratification of thyroid nodules with Bethesda III category: the experience of a territorial healthcare hospital. Cureus 2020; 12: e8202.
    OpenUrl
  13. 13.↵
    1. Haugen BR,
    2. Alexander EK,
    3. Bible KC,
    4. Doherty GM,
    5. Mandel SJ,
    6. Nikiforov YE, et al.
    2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26: 1–133.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. De D,
    2. Dutta S,
    3. Tarafdar S,
    4. Kar SS,
    5. Das U,
    6. Basu K, et al.
    Comparison between sonographic features and fine needle aspiration cytology with histopathology in the diagnosis of solitary thyroid nodule. Indian J Endocrinol Metab 2020; 24: 349–354.
    OpenUrl
  15. 15.↵
    1. Chirayath SR,
    2. Pavithran PV,
    3. Abraham N,
    4. Nair V,
    5. Bhavani N,
    6. Kumar H, et al.
    Prospective study of Bethesda categories III and IV thyroid nodules: outcomes and predictive value of BRAFV600E mutation. Indian J Endocrinol Metab 2019; 23: 278–281.
    OpenUrl
  16. 16.↵
    1. Yaprak Bayrak B,
    2. Eruyar AT.
    Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology. BMC Endocr Disord 2020; 20: 48.
    OpenUrl
  17. 17.↵
    1. Park VY,
    2. Kim EK,
    3. Kwak JY,
    4. Yoon JH,
    5. Moon HJ.
    Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology. Eur Radiol 2015; 25: 2601–2607.
    OpenUrl
  18. 18.↵
    1. Yoo WS,
    2. Choi HS,
    3. Cho SW,
    4. Moon JH,
    5. Kim KW,
    6. Park HJ, et al.
    The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance. Clin Endocrinol (Oxf) 2014; 80: 735–742.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Rago T,
    2. Scutari M,
    3. Santini F,
    4. Loiacono V,
    5. Piaggi P,
    6. Di Coscio G, et al.
    Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab 2010; 95: 5274–5280.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Basha MAA,
    2. Alnaggar AA,
    3. Refaat R,
    4. El-Maghraby AM,
    5. Refaat MM,
    6. Abd Elhamed ME, et al.
    The validity and reproducibility of the Thyroid Imaging Reporting and Data System (TI-RADS) in categorization of thyroid nodules: multicentre prospective study. Eur J Radiol 2019; 117: 184–192.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Middleton WD,
    2. Teefey SA,
    3. Reading CC,
    4. Langer JE,
    5. Beland MD,
    6. Szabunio MM, et al.
    Multiinstitutional analysis of thyroid nodule risk stratification using the American College of Radiology Thyroid Imaging Reporting and Data System. AJR Am J Roentgenol 2017; 208: 1331–1341.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Cibas ES,
    2. Ali SZ.
    The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017; 27: 1341–1346.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords